These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37764887)

  • 1. Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy.
    Passini F; Raccagni AR; Diotallevi S; Lolatto R; Bruzzesi E; Candela C; Bertoni C; Trentacapilli B; Lucente MF; Castagna A; Nozza S
    Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
    Mazzotta V; Lepri AC; Matusali G; Cimini E; Piselli P; Aguglia C; Lanini S; Colavita F; Notari S; Oliva A; Meschi S; Casetti R; Mondillo V; Vergori A; Bettini A; Grassi G; Pinnetti C; Lapa D; Tartaglia E; Gallì P; Mondi A; Montagnari G; Gagliardini R; Nicastri E; Lichtner M; Sarmati L; Tamburrini E; Mastroianni C; Stingone C; Siddu A; Barca A; Fontana C; Agrati C; Girardi E; Vaia F; Maggi F; Antinori A;
    EClinicalMedicine; 2024 Feb; 68():102420. PubMed ID: 38292040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.
    Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S;
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower rate of mpox vaccination hesitancy and medical consultation among Chinese men who have sex with men living with HIV in comparison with those living without HIV: A national observational study.
    Zheng M; Du M; Yang G; Yao Y; Qian X; Zhi Y; Ma L; Tao R; Zhu Z; Zhou F; Dai S; Yang J; Liu M; Liu J
    Hum Vaccin Immunother; 2023 Dec; 19(3):2290788. PubMed ID: 38054460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Mpox Knowledge, Stigma, and Willingness to Vaccinate for Mpox: Cross-Sectional Web-Based Survey Among Sexual and Gender Minorities.
    Torres TS; Silva MST; Coutinho C; Hoagland B; Jalil EM; Cardoso SW; Moreira J; Magalhaes MA; Luz PM; Veloso VG; Grinsztejn B
    JMIR Public Health Surveill; 2023 Jul; 9():e46489. PubMed ID: 37459174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox knowledge, vaccination and intention to reduce sexual risk practices among men who have sex with men and transgender people in response to the 2022 mpox outbreak: a cross-sectional study in Victoria, Australia.
    Chow EPF; Samra RS; Bradshaw CS; Chen MY; Williamson DA; Towns JM; Maddaford K; Mercury F; Fairley CK
    Sex Health; 2023 Oct; 20(5):390-402. PubMed ID: 37423606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection.
    Sönmez İ; Martínez Riveros H; Folch C; Suñer C; Díaz Y; Alonso L; Agusti C; Mendoza A; Tarín-Vicente EJ; Oller X; Alemany A; Rivero À; Orviz E; Silva-Klug A; Mitjà O; Casabona J;
    Sex Transm Infect; 2023 Dec; 99(8):541-547. PubMed ID: 37704363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
    Raccagni AR; Diotallevi S; Lolatto R; Lucente MF; Candela C; Gianotti N; Trentacapilli B; Canetti D; Castagna A; Nozza S
    AIDS; 2023 Dec; 37(15):2365-2369. PubMed ID: 37773029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
    Muller MP; Navarro C; Wilson SE; Shulha HP; Naus M; Lim G; Padhi S; McGeer A; Finkelstein M; Liddy A; Bettinger JA;
    Vaccine; 2024 Jan; 42(3):535-540. PubMed ID: 38199921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation.
    Agunbiade S; Burton F; Muirhead J; Whitlock GG; Girometti N
    Sex Transm Infect; 2023 May; 99(3):198-199. PubMed ID: 36596674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: a multivariable prediction model using causal inference methodology.
    MacGregor L; Kohli M; Looker KJ; Hickson F; Weatherburn P; Schmidt AJ; Turner KM
    Sex Transm Infect; 2021 Jun; 97(4):282-289. PubMed ID: 33452129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemsex among men who have sex with men during the Mpox health crisis in Brazil: A nationwide web survey.
    Santos GRS; Ribeiro CJN; Lima SVMA; Neto JC; de Sousa AR; Bulcao CDS; Dellagostini PG; Batista OMA; de Oliveira LB; Mendes IAC; de Sousa ÁFL
    Public Health Nurs; 2024; 41(3):589-601. PubMed ID: 38528749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.
    Alavian N; Mourad A; Woodhouse EW; Niehaus E; Cunningham H; Zavala S; Kohler P; Pappas S; Yarrington ME; Okeke NL; Wolfe CR; Cox GM; Dicks KV; Stout JE
    Open Forum Infect Dis; 2023 Sep; 10(9):ofad434. PubMed ID: 37662451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mpox across countries from Central and Eastern Europe - 2022 outbreak.
    Ianache I; Skrzat-Klapaczynska A; Jilich D; Fleischhans L; Gmizic I; Ranin J; Papadopoulos A; Protopapas K; Mulabdic V; Lakatos B; Nagy EL; Begovac J; Holban T; Sevgi DY; Cicic A; Yancheva N; Sojak L; Rukhadze N; Kowalska J; Oprea C;
    Travel Med Infect Dis; 2024; 59():102719. PubMed ID: 38574784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement in Chemsex among Men Who Have Sex with Men (MSM) in Malaysia: Prevalence and Associated Factors from an Online National Survey.
    Maviglia F; Wickersham JA; Azwa I; Copenhaver N; Kennedy O; Kern M; Khati A; Lim SH; Gautam K; Shrestha R
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey).
    Dukers-Muijrers NHTM; Evers Y; Widdershoven V; Davidovich U; Adam PCG; Op de Coul ELM; Zantkuijl P; Matser A; Prins M; de Vries HJC; den Heijer C; Hoebe CJPA; Niekamp AM; Schneider F; Reyes-Urueña J; Croci R; D'Ambrosio A; van der Valk M; Posthouwer D; Ackens R; Ter Waarbeek H; Noori T; Hoornenborg E
    Front Public Health; 2022; 10():1058807. PubMed ID: 36684959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perception of and Vaccine Readiness towards Mpox among Men Who Have Sex with Men Living with HIV in China: A Cross-Sectional Study.
    Fu L; Sun Y; Li Y; Wang B; Yang L; Tian T; Wu X; Peng X; Liu Q; Chen Y; Lin YF; Li H; Meng X; Zou H
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022.
    Siegenbeek van Heukelom ML; Jongen VW; Schouten J; Hoornenborg E; Bruisten S; Westerhuis B; Welkers MR; Vergunst CE; Prins M; Schim van der Loeff MF; de Vries HJC
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1891-1896. PubMed ID: 37212540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mpox vaccination for men who have sex with men and their differential risk of exposure and infection.
    Wong NS; Wong BC; Lee MP; Tsang OT; Cheung DKF; Sit AY; Wong SY; Lee SS
    Hum Vaccin Immunother; 2023 Aug; 19(2):2252263. PubMed ID: 37649367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc).
    Back S; Knox B; Coakley C; Deltour N; Jacquot E; Raad H; Garry EM
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.